Current aspects of pulmonary arterial hypertension and therapeutics

被引：1

作者：

Li, Xianchi ^{[1
]}

Liu, Yuanyuang ^{[1
]}

Zhang, Peiying ^{[1
]}

机构：

[1] Xuzhou Cent Hosp, Xuzhou, Peoples R China

来源：

MINERVA CARDIOANGIOLOGICA | 2017年 / 65卷 / 02期

关键词：

Hypertension; pulmonary; Therapeutics; Adrenergic beta-antagonists; RIGHT-VENTRICULAR FUNCTION; CALCIUM-CHANNEL BLOCKERS; LONG-TERM RESPONSE; SIGNALING CONTRIBUTES; AEROBIC EXERCISE; SURVIVAL; PROSTACYCLIN; MANAGEMENT; PHYSIOLOGY; DISEASE;

D O I：

10.23736/S0026-4725.16.04266-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The pulmonary arterial hypertension (PAH) patients have high rate of mortality due to right ventricle (or ventricular) (RV) failures. A lot of research work is being carried out in the area, however no treatment is available that could contrast the rise in mortality rates in PAH patients. beta 1-adrenoceptor blockers (beta-blockers, BB) reduced mortality in left heart failure, but they do not explored much at clinical level. Recent studies suggest beta-blockers might be beneficial in PAH; however the mechanisms remain unknown. The present review article would put light on all these aspects of PAH along with latest ways for the management of PAH.

引用

页码：173 / 178

页数：6

共 50 条

[31] Current Clinical Management of Pulmonary Arterial Hypertension [J].

Zamanian, Roham T. ;

Kudelko, Kristina T. ;

Sung, Yon K. ;

Perez, Vinicio de Jesus ;

Liu, Juliana ;

Spiekerkoetter, Edda .

CIRCULATION RESEARCH, 2014, 115 (01) :131-147

[32] Current Therapeutic Approaches to Pulmonary Arterial Hypertension [J].

Galie, Nazzareno ;

Palazzini, Massimiliano ;

Leci, Enri ;

Manes, Alessandra .

REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (06) :708-724

[33] Prostacyclin Therapy for Pulmonary Arterial Hypertension [J].

Ruan, Cheng-Huai ;

Dixon, Richard A. F. ;

Willerson, James T. ;

Ruan, Ke-He .

TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (04) :391-399

[34] Pulmonary arterial hypertension: current therapeutic strategies [J].

Puri, Aniket ;

McGoon, Michael D. ;

Kushwaha, Sudhir S. .

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (06) :319-329

[35] Tadalafil Therapy for Pulmonary Arterial Hypertension [J].

Galie, Nazzareno ;

Brundage, Bruce H. ;

Ghofrani, Hossein A. ;

Oudiz, Ronald J. ;

Simonneau, Gerald ;

Safdar, Zeenat ;

Shapiro, Shelley ;

White, R. James ;

Chan, Melanie ;

Beardsworth, Anthony ;

Frumkin, Lyn ;

Barst, Robyn J. .

CIRCULATION, 2009, 119 (22) :2894-U65

[36] Advances in the management of pulmonary arterial hypertension [J].

Deshwal, Himanshu ;

Weinstein, Tatiana ;

Sulica, Roxana .

JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (07) :1270-1280

[37] Pulmonary arterial hypertension and thyroid disease [J].

Silva, Denise Rossato ;

Gazzana, Marcelo Basso ;

John, Angela Beatriz ;

Siqueira, Debora Rodrigues ;

Silva Maia, Ana Luiza ;

Menna Barreto, Sergio Saldanha .

JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (02) :179-185

[38] Guidelines for the Treatment of Pulmonary Arterial Hypertension [J].

Vazquez, Zoe G. S. ;

Klinger, James R. .

LUNG, 2020, 198 (04) :581-596

[39] The burden of comorbidities in pulmonary arterial hypertension [J].

Lang, Irene M. ;

Palazzini, Massimiliano .

EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0K) :21-28

[40] Current and future treatments of pulmonary arterial hypertension [J].

Sommer, Natascha ;

Ghofrani, Hossein A. ;

Pak, Oleg ;

Bonnet, Sebastien ;

Provencher, Steve ;

Sitbon, Olivier ;

Rosenkranz, Stephan ;

Hoeper, Marius M. ;

Kiely, David G. .

BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (01) :6-30

← 1 2 3 4 5 →